Recent Quotes (30 days)

You have no recent quotes
chg | %

HeartWare International, Inc.  

(Public, ASX:HIN)   Watch this stock  
Find more results for ASX: HIN
0.0000
- Close
ASX data delayed by 20 mins - Disclaimer
Currency in
Range     -
52 week 2.00 - 3.06
Open     -
Vol / Avg. 0.00/25,614.00
Mkt cap     -
P/E     -
Div/yield     -
EPS -0.15
Shares     -
Beta     -
Inst. own     -

Key stats and ratios

Q2 (Jun '13) 2012
Net profit margin -25.44% -79.08%
Operating margin -18.56% -69.95%
EBITD margin - -65.42%
Return on average assets -15.46% -39.23%
Return on average equity -26.12% -89.97%
Employees 396 -
CDP Score - -

Address

500 Old Connecticut Path
FRAMINGHAM, MA 1701
United States - Map
+1-508-7390873 (Phone)
+1-508-7390948 (Fax)

Website links

Description

Heartware International, Inc. is a medical device company. The Company develops and manufactures miniaturized implantable heart pumps or ventricular assist devices to treat patients suffering from advanced heart failure. The Company operates in the segment of design and manufacture of medical devices. The HeartWare Ventricular Assist System (HVAD System), which includes a ventricular assist device (VAD) or blood pump, patient accessories and surgical tools, provides circulatory support for patients in the advanced stage of heart failure. The HVAD System is designed to be implanted adjacent to the heart, avoiding abdominal surgery. The HVAD System features the centrifugal pump designed to be implanted in the chest, directly adjacent to the heart. It develops MVAD System, a miniaturized device. The CircuLite Surgical System is designed to be implanted through a right, mini-thoracotomy procedure and does not require a sternotomy or cardiopulmonary bypass.